NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DropGenie

DropGenie

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://dropgenie.com/

Last Round

Seed

Jun 22, 2026

Total Funding Raised

$110,000

Momentum

Top 1%

of companies Caplight tracks

Company Overview

DropGenie is a biotechnology company that provides a microfluidics-based platform to miniaturize and automate gene editing workflows, enabling high-throughput cell engineering in precious patient samples for applications in personalized medicine and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

microfluidics platformgene editinglab automationCRISPR screeninglab-on-a-chipcell engineeringhigh-throughput screeningdrug discovery platformdigital microfluidicsHTSassay miniaturizationnon-viral transfectioncell and gene therapyfunctional genomicsAI-driven drug discoveryprimary patient cellsrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DropGenie Comps

Public and private peers based on sector, stage, and business model.

DropGenie comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DropGenie Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 22, 2026
AcceleratorMar 13, 2026
AcceleratorJul 6, 2022
AcceleratorAug 23, 2018

Key People

Founding team and executive leadership

Hugo Sinha

COO

Executive Team

Yen-Hsiang Wang

Chief Business Officer

Executive Team

DropGenie Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Led by Skeleton Key with participation from Merck Capital Ventures.

  • Mar 13, 2026

    $100K raised from Merck Capital Ventures and others.

DropGenie Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DropGenie Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DropGenie's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2018
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.